Could a ketamine mist lift the fog of depression?
NCT ID NCT06752759
First seen May 02, 2026 · Last updated May 06, 2026 · Updated 1 time
Summary
This study tests whether inhaling ketamine through a nebulizer can reduce symptoms of moderate to severe depression in adults. Participants will receive either ketamine or a placebo (midazolam) and be monitored for changes in mood over about 10 days. The goal is to find a fast-acting treatment for people who need relief while staying in the hospital.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL NERVOUS SYSTEM AGENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Maimonides Medical Center
RECRUITINGBrooklyn, New York, 11219, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.